Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864.SZ
36.39 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 1,102.013 | 823.444 | 419.305 | 382.003 | 117.684 | 85.123 | 301.472 | 125.67 | 80.484 | 105.13 | 67.788 |
| Short Term Investments
| -2.867 | -11.774 | 1.484 | 0 | 50.214 | 233.584 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,102.013 | 823.444 | 419.305 | 382.003 | 167.898 | 85.123 | 301.472 | 125.67 | 80.484 | 105.13 | 67.788 |
| Net Receivables
| 496.667 | 557.282 | 468.526 | 414.41 | 277.074 | 243.087 | 210.819 | 152.539 | 138.906 | 120.527 | 133.847 |
| Inventory
| 77.626 | 94.628 | 66.765 | 66.391 | 57.891 | 39.903 | 31.964 | 28.674 | 29.888 | 29.86 | 31.757 |
| Other Current Assets
| 1.496 | 6.595 | 1.851 | 0.603 | 188.054 | 230.267 | -2.836 | 1.1 | -1.315 | -2.147 | -12.459 |
| Total Current Assets
| 1,677.802 | 1,481.95 | 956.446 | 863.407 | 690.916 | 598.38 | 541.419 | 307.983 | 247.963 | 253.372 | 220.932 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 371.7 | 353.744 | 275.041 | 197.404 | 144.203 | 141.759 | 140.32 | 127.032 | 116.769 | 93.634 | 46.229 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 52.764 | 54.899 | 56.334 | 57.772 | 59.383 | 60.977 | 62.589 | 64.029 | 64.239 | 33.433 | 12.154 |
| Goodwill and Intangible Assets
| 52.764 | 54.899 | 56.334 | 57.772 | 59.383 | 60.977 | 62.589 | 64.029 | 64.239 | 33.433 | 12.154 |
| Long Term Investments
| 12.578 | 21.661 | 16.747 | 17.868 | 14.147 | 0 | -8.599 | -5.452 | 0 | 0 | 0 |
| Tax Assets
| 7.218 | 16.634 | 20.204 | 16.444 | 11.73 | 10.486 | 8.599 | 5.452 | 4.03 | 4.74 | 5.274 |
| Other Non-Current Assets
| 2.958 | 1.899 | 5.404 | 9.654 | 8.499 | 6.233 | 8.599 | 5.452 | 0.329 | 16.077 | 57.799 |
| Total Non-Current Assets
| 447.218 | 448.837 | 373.729 | 299.142 | 237.962 | 219.456 | 211.508 | 196.514 | 185.368 | 147.883 | 121.456 |
| Total Assets
| 2,125.02 | 1,930.787 | 1,330.175 | 1,162.549 | 928.878 | 817.836 | 752.927 | 504.497 | 433.331 | 401.255 | 342.389 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 91.432 | 121.668 | 66.008 | 58.808 | 36.626 | 40.967 | 50.933 | 49.853 | 47.515 | 35.528 | 34.362 |
| Short Term Debt
| 100.386 | 366.027 | 65.027 | 9.994 | -2.243 | -4.544 | 3 | 20 | 20 | 40 | 20 |
| Tax Payables
| 20.99 | 32.279 | 31.45 | 25.522 | 18.025 | 18.156 | 15.57 | 17.376 | 13.512 | 14.077 | 12.555 |
| Deferred Revenue
| 287.755 | 13.811 | 305.763 | 274.769 | 2.243 | 4.544 | 3.377 | 84.35 | 61.234 | 65.597 | 66.959 |
| Other Current Liabilities
| 0.835 | 401.172 | 0.757 | 0.609 | 198.05 | 146.076 | 121.475 | 3.122 | 2.846 | 2.002 | 2.072 |
| Total Current Liabilities
| 480.407 | 902.678 | 437.555 | 344.18 | 234.676 | 187.043 | 178.785 | 157.325 | 131.595 | 143.127 | 123.392 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 2.107 | 27.675 | 41.666 | 53.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 91.246 | 52.83 | 41.395 | 27.529 | 17.08 | 17.444 | 18.559 | 19.357 | 12.846 | 11.936 | 8.155 |
| Deferred Tax Liabilities Non-Current
| -91.246 | 0 | 2.351 | 1.827 | 2.413 | 1.751 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 91.246 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 93.353 | 80.506 | 85.412 | 82.706 | 19.493 | 19.195 | 18.559 | 19.357 | 12.846 | 11.936 | 8.155 |
| Total Liabilities
| 573.76 | 983.183 | 522.967 | 426.886 | 254.168 | 206.238 | 197.344 | 176.681 | 144.441 | 155.062 | 131.547 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 106.281 | 86.714 | 86.67 | 86.67 | 86.67 | 86.67 | 86.67 | 65 | 65 | 65 | 65 |
| Retained Earnings
| 574.396 | 492.843 | 415.766 | 342.921 | 284.296 | 227.965 | 178.313 | 138.946 | 102.974 | 64.384 | 29.016 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 107.43 | 47.793 | 39.929 | 32.44 | 25.659 | 19.296 | 123.869 | 120.28 | -0 | 0 |
| Other Total Stockholders Equity
| 868.368 | 242.664 | 241.155 | 251.257 | 271.304 | 271.304 | 271.304 | 0 | 0 | 116.231 | 117.518 |
| Total Shareholders Equity
| 1,549.045 | 929.651 | 791.385 | 720.777 | 674.709 | 611.598 | 555.583 | 327.816 | 288.254 | 245.616 | 211.534 |
| Total Equity
| 1,551.259 | 947.604 | 807.207 | 735.663 | 674.709 | 611.598 | 555.583 | 327.816 | 288.89 | 246.193 | 210.842 |
| Total Liabilities & Shareholders Equity
| 2,125.02 | 1,930.787 | 1,330.175 | 1,162.549 | 928.878 | 817.836 | 752.927 | 504.497 | 433.331 | 401.255 | 342.389 |